$tltff The FDA wants an option that has rates better thenflipping a coin.
a 50 50 percent chance of keeping your bladder is not optimistic.
the FDA wants better numbers.
TLTFF study continues to treat patients and heal cancer.
TLTFF is the NMIBC nonresponse darling.
The AEs are all resolved except for 1 grade 5 probally cause by an elderly patient or other factor then TLD-1433 OR THE DEVICE.
Theralase® believes all SAEs reported to date are unrelated to the Study Drug or Study Device, subject to final review and confirmation by the independent Data Safety Monitoring Board (“DSMB”).